Chordia Therapeutics Inc. (TSE: 190A)
Health Care · Biotechnology · JP
¥56.00
-1.75% today · -52.1% 1Y
Chordia Therapeutics Inc. (TSE: 190A) operates in the Biotechnology industry within the Health Care sector. The company is valued at $27.40M and employs 20 people.
Over the last twelve months the share price has lost 52.1%, trading between 55.00 and 179.00.
Tweenvest scores Chordia Therapeutics Inc. across four factors: quality 73/100, value 15/100. Its strongest factor is quality.
190A price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.40M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -19.74
- Dividend yield
- —
- Beta (5Y)
- 3.07
- 52-week high
- ¥179.00
- 52-week low
- ¥55.00
- Avg volume (3M)
- —
- Shares outstanding
- 77.26M
- Employees
- 20
- Next earnings
- —
About Chordia Therapeutics Inc.
Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
- ISIN
- JP3283730004
- Founded
- 2017
- Listed since
- Jun 14, 2024
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Intervacc AB (publ)OM: IVACC | $28.25M | Skr0.82 | -7.44% |
| Matricelf LtdTASE: MTLF | $27.79M | ₪2.60 | +4.20% |
| Zenotech Laboratories LimitedBSE: 532039 | $27.69M | Rs43.06 | -0.02% |
| Kohjin Bio Co., Ltd.TSE: 177A | $27.45M | ¥848.00 | +4.05% |
| IMB Dx, Inc.KOSDAQ: A461030 | $27.39M | ₩2,605.00 | -8.44% |
| LabGenomics Co., Ltd.KOSDAQ: A084650 | $27.17M | ₩2,440.00 | -12.07% |
| Isofol Medical AB (publ)OM: ISOFOL | $26.73M | Skr0.83 | +3.51% |
| Kim Forest Enterprise Co., Ltd.TWSE: 6645 | $26.71M | NT$14.35 | +6.30% |
Figures last refreshed Oct 18, 2026.